ad image

Early Targeting of Chronic Inflammation That Precedes and Causes Synaptic Loss

Jul 29, 2021PTV-07-21-CL-001

On this episode of Pharma's Almanac TV, our Scientific Editor in Chief, David Alvaro, talks to INmune Bio's President and CEO Raymond J. Tesi about the company's unique and revolutionary treatment of chronic inflammation that causes Alzheimer's.